BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
BIVI
BioVie Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for BIVI
Full BIVI profile on Quantisnow Follow BIVI and get a push notification the moment its next story breaks.